We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABUS icon
2076
Arbutus Biopharma
ABUS
$915M
$21K ﹤0.01%
8,652
+7,180
+488% +$20.9K
AMSC icon
2077
American Superconductor
AMSC
$1.59B
$21K ﹤0.01%
2,739
+1,608
+142% +$12K
BANF icon
2078
BancFirst
BANF
$3.8B
$21K ﹤0.01%
+458
New +$18.4K
BSET icon
2079
Bassett Furniture
BSET
$176M
$21K ﹤0.01%
683
-3,434
-83% -$92.9K
CRVS icon
2080
Corvus Pharmaceuticals
CRVS
$1.17B
$21K ﹤0.01%
+1,427
New +$21.7K
DORM icon
2081
Dorman Products
DORM
$4.18B
$21K ﹤0.01%
+289
New +$19.7K
ENVA icon
2082
Enova International
ENVA
$6.29B
$21K ﹤0.01%
1,720
+1,230
+251% +$13.3K
FFBC icon
2083
First Financial Bancorp
FFBC
$3.53B
$21K ﹤0.01%
+762
New +$18.8K
TDAY
2084
USA Today Co
TDAY
$1.06B
$21K ﹤0.01%
+1,339
New +$20.7K
GLDD
2085
DELISTED
Great Lakes Dredge & Dock
GLDD
$21K ﹤0.01%
5,148
-1,811
-26% -$7.35K
HCI icon
2086
HCI Group
HCI
$2.41B
$21K ﹤0.01%
530
+413
+353% +$13.2K
HL icon
2087
Hecla Mining
HL
$11.3B
$21K ﹤0.01%
3,966
-109,282
-96% -$641K
IMMR icon
2088
Immersion
IMMR
$252M
$21K ﹤0.01%
+1,968
New +$18.6K
TBHC
2089
DELISTED
The Brand House Collective
TBHC
$21K ﹤0.01%
1,335
+1,199
+882% +$16.8K
LAZ icon
2090
Lazard
LAZ
$4.31B
$21K ﹤0.01%
518
-2,616
-83% -$102K
LKFN icon
2091
Lakeland Financial Corp
LKFN
$1.53B
$21K ﹤0.01%
+437
New +$17.8K
NWN icon
2092
Northwest Natural Holdings
NWN
$2.12B
$21K ﹤0.01%
+359
New +$20.9K
PGRE
2093
DELISTED
Paramount Group
PGRE
$21K ﹤0.01%
1,300
+814
+167% +$12.8K
RWT
2094
Redwood Trust
RWT
$594M
$21K ﹤0.01%
1,356
+1,093
+416% +$16K
SCCO icon
2095
Southern Copper
SCCO
$166B
$21K ﹤0.01%
725
-10,120
-93% -$285K
SMBC icon
2096
Southern Missouri Bancorp
SMBC
$850M
$21K ﹤0.01%
+570
New +$16.2K
TFX icon
2097
Teleflex
TFX
$5.98B
$21K ﹤0.01%
132
-1,228
-90% -$191K
TILE icon
2098
Interface
TILE
$2.22B
$21K ﹤0.01%
1,127
+1,016
+915% +$17.5K
TRUP icon
2099
Trupanion
TRUP
$1.18B
$21K ﹤0.01%
1,327
+927
+232% +$14.9K
WMK icon
2100
Weis Markets
WMK
$1.86B
$21K ﹤0.01%
+317
New +$18.3K
82 83
84
85 86

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.